The proposed legislation, General Assembly Raised Bill No. 7022, aims to enhance equity in Medicaid coverage for fertility health care by mandating the inclusion of fertility diagnostic care, fertility preservation services, and fertility treatment in the Medicaid state plan. Effective January 1, 2026, the bill defines key terms related to fertility care, including "fertility diagnostic care," "fertility preservation services," "fertility treatment," and "infertility." It specifies that coverage must include medically necessary ovulation-enhancing drugs and at least three cycles of ovulation-enhancing medication treatment aimed at achieving a live birth.

Additionally, the bill requires the Commissioner of Social Services to submit a report by July 1, 2026, to the relevant legislative committees. This report will assess the costs and benefits of including in-vitro fertilization as a covered benefit under the state medical assistance program, including potential Medicaid waivers and necessary state funding. The bill does not propose any deletions from current law but introduces new provisions to expand Medicaid coverage for fertility health care.